Skip to main content
Mijn bibliotheek
Ga naar:
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
BSL Shop
Inloggen

Welkom bij Erasmus MC & Bohn Stafleu van Loghum

Erasmus MC heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen. Je kunt je links eenvoudig registreren. Met deze gegevens kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL.

» Andere revante producten voor Erasmus MC studenten en medewerkers.

Registreer

Om ook buiten de locaties van Erasmus MC, thuis bijvoorbeeld, van Mijn BSL gebruik te kunnen maken, moet je jezelf eenmalig registreren. Dit kan alleen vanaf een computer op een van de locaties van Erasmus MC.

Eenmaal geregistreerd kun je thuis of waar ook ter wereld onbeperkt toegang krijgen tot Mijn BSL.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Inloggen
Top
Neuropraxis
Gepubliceerd in:

01-10-2009 | Artikelen

De langetermijngevolgen van mdma-gebruik op het serotonerge systeem, het werkgeheugen en impulsiviteit

Auteur: Drs. Jeroen Heijden

Gepubliceerd in: Neuropraxis | Uitgave 5/2009

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Samenvatting

3,4-methyleendioxymethamfetamine (mdma), ook wel xtc of ecstasy genoemd, is een populaire recreatieve drug (De Win et al., 2005; Jellinek, 2007). Er bestaan vermoedens dat het gebruik op de lange termijn schadelijke gevolgen heeft voor het serotonerge systeem en daarmee op fysiek, emotioneel en cognitief gebied (Gouzoulis-Mayfrank & Daumann, 2006a, McCann et al., 2008; Thomasius et al., 2006). Het mdma-onderzoek kent een aantal complicerende factoren van grotendeels methodologische aard, die zijn besproken in Neuropraxis 4, 2009, 83-88. Dit artikel beperkt zich tot een analyse van de gevolgen op lange termijn, vanaf een aantal maanden, van mdma-gebruik op de serotoninehuishouding en twee cognitieve aspecten: werkgeheugen en impulsiviteit.
vorige artikel Restauratieve functietraining bij cerebrale blindheid: hoognodig of overbodig?
volgende artikel Artikelen
Literatuur
Allen, P.P., Cleare, A.J., Lee, F., Fusar-Poli, P., Tunstall, N., Fu, C. H. et al. (2006). Effect of acute tryptophan depletion on pre-frontal engagement. Psychopharmacology (Berlijn), 187,4, 486-497.
Ashcraft, M.H. (2002). Cognition (3 ed.). New Jersey: Pearson Education.
Back-Madruga, C., Boone, K.B., Chang, L., Grob, C.S., Lee, A., Nations, H. et al. (2003). Neuropsychological effects of 3,4-methylenedioxymethamphetamine (mdma or ecstasy) in recreational users. Clinical Neuropsychology, 17,4, 446-459.
Bedi, G. & Redman, J. (2008). Psychological Medicine, 38, 1319–1330.
Bogt, T. F. ter & Engels, R.C. (2005). ‘Partying’ hard: party style, motives for and effects of mdma use at rave parties. Substance Use & Misuse, 40,9-10, 1479-1502.
Buchert, R., Schulze, O., Wilke, F., Berding, G., Thomasius, R., Petersen, K. et al. (2006). Is correction for age necessary in spect or pet of the central serotonin transporter in young, healthy adults? Journal of Nuclear Medicine, 47,1, 38-42.
Buchert, R., Thomasius, R., Nebeling, B., Petersen, K., Obrocki, J., Jenicke, L. et al. (2003). Long-term effects of ‘ecstasy’ use on serotonin transporters of the brain investigated by pet. Journal of Nuclear Medicine, 44,3, 375-384.
Buchert, R., Thomasius, R., Wilke, F., Petersen, K., Nebeling, B., Obrocki, J. et al. (2004). A voxel-based pet investigation of the long-term effects of ‘Ecstasy’ consumption on brain serotonin transporters. American Journal of Psychiatry, 161,7, 1181-1189.
Chamberlain, S.R., Muller, U., Robbins, T. W. & Sahakian, B. J. (2006). Neuropharmacological modulation of cognition. Current Opinion in Neurology, 19,6, 607-612.
Clark, L., Roiser, J.P., Robbins, T.W. & Sahakian, B.J., (2009). Disrupted ‘reflection’ impulsivity in cannabis users but not current or former ecstasy users. Journal of Psychopharmacology, 23,1, 14-22.
Clemens, K.J., McGregor, I.S., Hunt, G.E., & Cornish, J.L. (2007). mdma, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research. Drug and Alcohol Review, 26,1, 9-15.
Cowan, R.L. (2007). Neuroimaging research in human mdma users: a review. Psychopharmacology (Berlijn), 189,4, 539-556.
Cowan, R.L., Haga, E., de, B.F.B., Dietrich, M.S., Vimal, R.L., Lukas, S.E. et al. (2006). mdma use is associated with increased spatial bold fmri visual cortex activation in human mdma users. Pharmacology Biochemistry and Behavior, 84,2, 219-228.
Dafters, R.I. (2006). Impulsivity, inhibition and negative priming in ecstasy users. Addictive Behaviors, 31,8, 1436-1441.
Daumann, J., Jr., Fischermann, T., Heekeren, K., Thron, A. & Gouzoulis-Mayfrank, E. (2004). Neural mechanisms of working memory in ecstasy (mdma) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study. Biological Psychiatry, 56,5, 349-355.
De Sola Llopis, S., Miguelez-Pan, M., Peña-Casanova, J., Poudevida, S., Farré, M., Pacifici, R., Böhm, P., Abanades, S., Verdejo García, A., Langohr, K., Zuccaro P. & de la Torre, R.(2008). Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study. Journal of Psychopharmacology, 22, 498-510.
Frei, E., Gamma, A., Pascual-Marqui, R., Lehmann, D., Hell, D. & Vollenweider, F. X. (2001). Localization of mdma-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (loreta). Human Brain Mapping, 14,3, 152-165.
Fox, H.C., McLean, A., Turner, J.J., Parrott, A.C., Rogers, R. & Sahakian, B.J. (2002). Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free mdma (‘ecstasy’) polydrug users. Psychopharmacology (Berlijn), 162,2, 203-214.
Gazzaniga, M.S., Ivry, R.B., Mangun, G.R. (2002). Cognitive Neuroscience: The Biology of the Mind (2 ed.). New York: W. W. Norton & Company.
Gouzoulis-Mayfrank, E. & Daumann, J. (2006a). Neurotoxicity of methylenedioxyamphetamines (mdma; ecstasy) in humans: how strong is the evidence for persistent brain damage? Addiction, 101,3, 348-361.
Gouzoulis-Mayfrank, E. & Daumann, J. (2006b). The confounding problem of polydrug use in recreational ecstasy/mdma users: a brief overview. Journal of Psychopharmacology, 20,2, 188-193.
Gouzoulis-Mayfrank, E., Thimm, B., Rezk, M., Hensen, G. & Daumann, J. (2003). Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Progress in Neuro-psychopharmacology and Biological Psychiatry, 27,5, 819-827.
Green, A.R., Mechan, A.O., Elliott, J.M., O’Shea, E. & Colado, M.I. (2003). The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (mdma, ‘ecstasy’). Pharmacological Reviews, 55,3, 463-508.
Han, D.D., & Gu, H.H. (2006). Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. bmc Pharmacology, 6, 6.
Hanson, K.L., Luciana, M. & Sullwold, K.(2008). Reward-related decision-making deficits and elevated impulsivity among mdma and other drug users. Drug and Alcohol Dependence, 96,1-2, 99-110.
Jacobsen, L.K., & Mencl, W. (2004). Preliminary evidence of hippocampal dysfunction in adolescent mdma (‘ecstasy’) users: possible relationship to neurotoxic effects. Psychopharmacology (Berlijn), 173,3-4, 383-390.
Jager, G, Win, M.M.L. de, Tweel, I. van der, Schilt, T., Kahn, R.S., Brink, W. van den, Ree, J.M. van & Ramsey, N.F. (2007). Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an fmri study. Neuropsychopharmacology, 33,2, 247-258.
McCann, U. D., Szabo, Z., Seckin, E., Rosenblatt, P., Mathews, W. B., Ravert, H. T., et al. (2005). Quantitative pet studies of the serotonin transporter in mdma users and controls using [11C]McN5652 and [11C]DASB. Neuropsychopharmacology, 30(9), 1741-1750.
McCann, U.D., Szabo, Z., Vranesic, M., Palermo, M., Mathews, W.B., Ravert, H.T., Dannals, R.F. & Ricaurte, G.A. (2008). Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent 3, 4-methylenedioxymethamphetamine (‘ecstasy’) users: relationship to cognitive performance. Psychopharmacology, 200,3, 439-450.
Moeller, F.G., Steinberg, J.L., Dougherty, D.M., Narayana, P. ., Kramer, L.A., & Renshaw, P.F. (2004). Functional mri study of working memory in mdma users. Psychopharmacology (Berlijn), 177,1-2, 185-194.
Montgomery, C., Fisk, J.E., Newcombe, R., Wareing, M. & Murphy, P.N. (2005). Syllogistic Reasoning Performance in mdma (Ecstasy) Users. Experimental and Clinical Pharmacology, 13,2, 137-45
Mowla, A., Mosavinasab, M. & Pani, A. (2007). Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial. Journal of Clinical Psychopharmacology, 27,1, 67-70.
Neath, I.S. & Surprenant, A.M. (2003). Human Memory. Belmont: Wadsworth/Thomson Learning.
O’Shea, E., Escobedo, I., Orio, L., Sanchez, V., Navarro, M., Green, A.R. et al. (2005). Elevation of ambient room temperature has differential effects on mdma-induced 5-ht and dopamine release in striatum and nucleus accumbens of rats. Neuropsychopharmacology, 30,7, 1312-1323.
Parrott, A.C., Rodgers, J., Buchanan, T., Ling, J., Heffernan, T. & Scholey, A.B. (2006). Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational mdma users. Human Psychopharmacology, 21,5, 285-298.
Quednow, B.B., Kuhn, K. ., Hoppe, C., Westheide, J., Maier, W., Daum, I. et al. (2007). Elevated impulsivity and impaired decision-making cognition in heavy users of mdma (‘Ecstasy’). Psychopharmacology (Berlijn), 189,4, 517-530.
Raj, V., Liang, H., Woodward, N., Bauernfeind, A., Lee, J., Dietrich, M., Park, S. & Cowan, R. (2009). mdma (ecstasy) use is associated with reduced bold signal change during semantic recognition in abstinent human polydrug users: a preliminary fmri study. Journal of Psychopharmacology, 0, 1-15.
Reneman, L., Booij, J., de Bruin, K., Reitsma, J.B., Wolff, F. A. de, Gunning, W. B. et al. (2001a). Effects of dose, sex, and long-term abstention from use on toxic effects of mdma (ecstasy) on brain serotonin neurons. Lancet, 358,9296, 1864-1869.
Reneman, L., Win, M.M. de, Brink, W., van den Booij, J. & Heeten, G.J. den (2006). Neuroimaging findings with mdma/ecstasy: technical aspects, conceptual issues and future prospects. Journal of Psychopharmacology, 20,2, 164-175.
Roiser, J.P., Rogers, R.D., Cook, L.J. & Sahakian, B.J. (2006). The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls. Psychopharmacology (Berlijn), 188,2, 213-227.
Roiser, J.P., Rogers, R.D. & Sahakian, B. . (2007). Neuropsychological function in ecstasy users: a study controlling for polydrug use. Psychopharmacology (Berlijn), 189,4, 505-516.
Schilt T., Goudriaan, A.E., Koeter, M.W., Brink, W. van den, & Schmand. B, (2009). Decision making as a predictor of first ecstasy use: a prospective study. Psychopharmacology (Berlijn), 203,3, 519-27.
Schilt, T., Win, M.M. de, Jager, G., Korf, D.J., Brink, W. van den et al. (2007). Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Archives of General Psychiatry, 64,6, 728-736.
Schilt, T., Win, M.M. de, Jager, G., Koeter, M., Ramsey, N.F., Schmand, B., Brink, W. van den, (2008). Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users. Psychological Medicine, 38,09, 1309-1317.
Schmitt, J.A., Wingen, M., Ramaekers, J.G., Evers, E.A. & Riedel, W.J. (2006). Serotonin and human cognitive performance. Current Pharmaceutical Design, 12,20, 2473-2486.
Soar, K., & Parrott, A. (2004). Persistent neuropsychological problems after 7 years of abstinence from recreational ecstasy (mdma): A case study. Psychological Reports, 95,2, 192-196.
Szabo, Z., McCann, U.D., Wilson, A.A., Scheffel, U., Owonikoko, T., Mathews, W. B. et al. (2002). Comparison of (+)-(11)C-McN5652 and (11)c-dasb as serotonin transporter radioligands under various experimental conditions. Journal of Nuclear Medicine, 43,5, 678-692.
Terner, J., & Wit, H. de (2006). Menstrual cycle phase and responses to drugs of abuse in humans. Drug and alcohol dependence, 84, 1-13.
Thomasius, R., Petersen, K., Buchert, R., Andresen, B., Zapletalova, P., Wartberg, L. et al. (2003). Mood, cognition and serotonin transporter availability in current and former ecstasy (mdma) users. Psychopharmacology (Berlijn), 167,1, 85-96.
Thomasius, R., Zapletalova, P., Petersen, K., Buchert, R., Andresen, B., Wartberg, L. et al. (2006). Mood, cognition and serotonin transporter availability in current and former ecstasy (mdma) users: the longitudinal perspective. Journal of Psychopharmacology, 20,2, 211-225.
Verdejo-Garcia, A., Lawrence, A.J. & Clark, L. (2008). Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neuroscience and Biobehavioral Reviews, 32, 777-810.
Verheyden, S.L., Henry, J.A. & Curran, H. . (2003). Acute, sub-acute and long-term subjective consequences of ‘ecstasy’ (mdma) consumption in 430 regular users. Human Psychopharmacology, 18,7, 507-517.
Wager, T.D., & Smith, E.E. (2003). Neuroimaging studies of working memory: a meta-analysis. Cognitive, Affective and Behavioural Neuroscience, 3,4, 255-274.
Wareing, M., Fisk, J.E., Montgomery, C., Murphy, P.N. & Chandler, M.D. (2007). Information processing speed in ecstasy (mdma) users. Human Psychopharmacology, 22,2, 81-88.
Wareing, M., Fisk, J.E., Murphy, P. & Montgomery, C. (2004). Verbal working memory deficits in current and previous users of mdma. Human Psychopharmacology, 19,4, 225-234.
Wareing, M., Fisk, J.E., Murphy, P., & Montgomery, C. (2005). Visuo-spatial working memory deficits in current and former users of mdma (‘ecstasy’). Human Psychopharmacology, 20,2, 115-123.
Win, M.M. de , Jager, G., Vervaeke, H.K., Schilt, T., Reneman, L., Booij, J. et al. (2005). The Netherlands xtc Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. International Journal of Methods in Psychiatric Research, 14,4, 167-185.
Win, M.M. de, Reneman, L., Jager, G., Vlieger, E.J., Olabarriaga, S.D., Lavini, C. et al. (2007). A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. Neuropsychopharmacology, 32,2, 458-470.
Win, M.M. de, Reneman, L., Reitsma, J B., Heeten, G.J. den, Booij, J. & Brink, W. van den (2004). Mood disorders and serotonin transporter density in ecstasy users - the influence of long-term abstention, dose, and gender. Psychopharmacology (Berlijn), 173,3-4, 376-382.
Win, M.M. de, Schilt, T., Reneman, L., Vervaeke, H., Jager, G., Dijkink, S., Booij, J. & Brink, W. van den (2006). Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study. Journal of Psychopharmacology, 20,2, 226-35.
Zakzanis, K.K., & Young, D.A. (2001). Memory impairment in abstinent mdma (‘Ecstasy’) users: a longitudinal investigation. Neurology, 56,7, 966-969.
Metagegevens
Titel
De langetermijngevolgen van mdma-gebruik op het serotonerge systeem, het werkgeheugen en impulsiviteit
Auteur
Drs. Jeroen Heijden
Publicatiedatum
01-10-2009
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Neuropraxis / Uitgave 5/2009
Print ISSN: 1387-5817
Elektronisch ISSN: 1876-5785
DOI
https://doi.org/10.1007/BF03080165

Andere artikelen Uitgave 5/2009

Artikelen

  • Signalement

Verschenen

  • Signalement

Restauratieve functietraining bij cerebrale blindheid: hoognodig of overbodig?

  • Artikelen

Woorden vooraf

  • Redactioneel

Agenda

  • Agenda

De ziekte van Parkinson: motorische symptomen, cognitieve beperkingen en depressie

  • Artikelen